Disulfide Bonds within the C2 Domain of RAGE Play Key Roles in Its Dimerization and Biogenesis

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Wei, Wen ^a   Lampe, Leonie ^a   Park, Sungha ^a   Vangara, Bhavana S ^a   Waldo, Geoffrey S ^b   Cabantous, Stephanie ^b   Subaran, Sarah S ^a   Yang, Dongmei ^a   Lakatta, Edward G ^a   Lin, Li ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CYSTEINE; GREEN FLUORESCENT PROTEIN; MUTANT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CHO CELL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS LINKING; DIMERIZATION; DISULFIDE BOND; ENDOPLASMIC RETICULUM; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG PARENCHYMA; MOUSE; MUTAGENESIS; NONHUMAN; OLIGOMERIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; CYSTEINE; DISULFIDES; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GLYCOSYLATION; HELA CELLS; HUMANS; MICE; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 84871297253     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050736     Document Type: Article

References (45)

1. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, et al. (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267: 14987-14997.
2. Ahmed N, Ahmed U, Thornalley PJ, Hager K, Fleischer G, et al. (2005) Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment. J Neurochem 92: 255-263.
3. He M, Kubo H, Morimoto K, Fujino N, Suzuki T, et al. (2011) Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep 12: 358-364.
4. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, et al. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901.
5. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, et al. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360.
6. Yan SD, Chen X, Fu J, Chen M, Zhu H, et al. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.
7. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, et al. (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198: 1507-1515.
8. Lin L, (2006) RAGE on the Toll Road? Cell Mol Immunol 3: 351-358.
9. Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, et al. (2007) A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 26: 1129-1139.
10. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, et al. (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83: 876-886.
11. Yan SF, Ramasamy R, Schmidt AM, (2009) Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J Mol Med 87: 235-247.
12. Lin L, Park S, Lakatta EG, (2009) RAGE signaling in inflammation and arterial aging. Front Biosci 14: 1403-1413.
13. Thornalley PJ, (2005) Dicarbonyl intermediates in the maillard reaction. Ann N Y Acad Sci 1043: 111-117.
14. Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, et al. (2007) Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 62: 427-433.
15. Yan SF, D'Agati V, Schmidt AM, Ramasamy R, (2007) Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Curr Mol Med 7: 699-710.
16. Yan SF, Ramasamy R, Schmidt AM, (2009) The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease. Expert Rev Mol Med 11: e9.
17. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, et al. (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8: 487-496.
18. Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, et al. (2008) Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 205: 3007-3018.
19. Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, et al. (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462: 99-103.
20. Xie J, Reverdatto S, Frolov A, Hoffmann R, Burz DS, et al. (2008) Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem 283: 27255-27269.
21. Lin L, DeMartino GN, Greene WC, (2000) Cotranslational dimerization of the Rel homology domain of NF-kB1 generates p50-p105 heterodimers and is required for effective p50 production. EMBO J 19: 4712-4722.
22. Pang J, Zeng X, Xiao RP, Lakatta EG, Lin L, (2009) Design, generation, and testing of mammalian expression modules that tag membrane proteins. Protein Sci 18: 1261-1271.
23. Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, et al. (2004) Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113: 1641-1650.
24. Pedelacq JD, Cabantous S, Tran T, Terwilliger TC, Waldo GS, (2006) Engineering and characterization of a superfolder green fluorescent protein. Nat Biotechnol 24: 79-88.
25. Vembar SS, Brodsky JL, (2008) One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 9: 944-957.
26. Ahner A, Brodsky JL, (2004) Checkpoints in ER-associated degradation: excuse me, which way to the proteasome? Trends Cell Biol 14: 474-478.
27. Nakatsukasa K, Brodsky JL, (2008) The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulum. Traffic 9: 861-870.
28. Katiyar S, Li G, Lennarz WJ, (2004) A complex between peptide:N-glycanase and two proteasome-linked proteins suggests a mechanism for the degradation of misfolded glycoproteins. Proc Natl Acad Sci U S A 101: 13774-13779.
29. Park H, Suzuki T, Lennarz WJ, (2001) Identification of proteins that interact with mammalian peptide:N-glycanase and implicate this hydrolase in the proteasome-dependent pathway for protein degradation. Proc Natl Acad Sci U S A 98: 11163-11168.
30. Dattilo BM, Fritz G, Leclerc E, Kooi CW, Heizmann CW, et al. (2007) The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry 46: 6957-6970.
31. Zong H, Madden A, Ward M, Mooney MH, Elliott CT, et al. (2010) Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction. J Biol Chem 285: 23137-23146.
32. Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, et al. (2003) Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 370: 1097-1109.
33. Walter P, Gilmore R, Blobel G, (1984) Protein translocation across the endoplasmic reticulum. Cell 38: 5-8.
34. Schlessinger J, (2002) Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110: 669-672.
35. Koch M, Chitayat S, Dattilo BM, Schiefner A, Diez J, et al. (2010) Structural Basis for Ligand Recognition and Activation of RAGE. Structure 18: 1342-1352.
36. Xie J, Burz DS, He W, Bronstein IB, Lednev I, et al. (2007) Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J Biol Chem 282: 4218-4231.
37. Hanford LE, Enghild JJ, Valnickova Z, Petersen SV, Schaefer LM, et al. (2004) Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem 279: 50019-50024.
38. Janssen-Heininger YM, Aesif SW, van der Velden J, Guala AS, Reiss JN, et al. Regulation of apoptosis through cysteine oxidation: implications for fibrotic lung disease. Ann N Y Acad Sci 1203: 23-28.
39. Kinnula VL, Vuorinen K, Ilumets H, Rytila P, Myllarniemi M, (2007) Thiol proteins, redox modulation and parenchymal lung disease. Curr Med Chem 14: 213-222.
40. Matthias LJ, Yam PT, Jiang XM, Vandegraaff N, Li P, et al. (2002) Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat Immunol 3: 727-732.
41. Schwertassek U, Balmer Y, Gutscher M, Weingarten L, Preuss M, et al. (2007) Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1. EMBO J 26: 3086-3097.
42. Kamata H, Hirata H, (1999) Redox regulation of cellular signalling. Cell Signal 11: 1-14.
43. Allen RG, Tresini M, (2000) Oxidative stress and gene regulation. Free Radic Biol Med 28: 463-499.
44. Chen VM, Hogg PJ, (2006) Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost 4: 2533-2541.
45. Matthias LJ, Hogg PJ, (2003) Redox control on the cell surface: implications for HIV-1 entry. Antioxid Redox Signal 5: 133-138.